PLX
Protalix Biotherapeutics Inc
2.70$
+0.7%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -55.4% | +38.8% | +120.1% | +18.4% | -67.2% | +84.4% | +6.3% | +155.0% | +119.0% | -61.4% | +17.3% | +16.3% | +24.6% | +21.9% | -49.3% | -1.6% | +80.7% | -41.9% | -43.2% | +87.6% | -29.1% | +88.2% | -45.6% | +62.0% | -39.2% | +11.3% | +265.8% | -70.5% | +1.4% | -64.3% | +259.5% | +33.3% | +1.4% | -44.5% | +54.8% | +14.0% | -48.9% | +270.0% | -41.0% | – | |
| – | -54.0% | +7.0% | +164.5% | +9.8% | -74.4% | +88.2% | -25.3% | -12.2% | +18.8% | -10.2% | +31.8% | +18.9% | -8.0% | +16.1% | -46.7% | +57.0% | -4.0% | +73.1% | -0.7% | -21.8% | -15.0% | +91.7% | -32.3% | +73.1% | -66.1% | +28.7% | +99.3% | -20.4% | +81.0% | -70.6% | +263.4% | -11.4% | -53.6% | +110.5% | -28.2% | +41.8% | -44.5% | -10.7% | +88.1% | – | |
| – | -69.4% | +520.9% | +4.2% | +74.9% | -37.3% | +78.0% | -110.9% | – | +137.5% | -66.1% | +13.8% | +15.6% | +34.1% | +23.0% | -49.8% | -13.3% | +111.3% | -60.8% | -74.2% | +393.0% | -35.3% | +86.1% | -53.6% | +52.4% | -12.5% | +4.5% | +344.8% | -81.2% | -70.1% | -29.7% | +250.6% | +138.5% | +49.5% | -86.5% | +406.4% | -2.7% | -52.7% | +557.9% | -59.0% | – | |
| – | +12.9% | -18.9% | +90.7% | -27.6% | +40.7% | -28.3% | +12.4% | +39.1% | -1.0% | +17.3% | +13.9% | -24.9% | -4.0% | +7.8% | -11.2% | -16.3% | +42.5% | -35.0% | +8.0% | -5.3% | +4.9% | +14.7% | -13.6% | -2.5% | -24.0% | +4.1% | -23.5% | -18.0% | -15.5% | -6.9% | +2.6% | +1.2% | +37.6% | -15.7% | +72.4% | -25.5% | +26.1% | -3.7% | -19.8% | – | |
| – | +56.0% | -19.2% | +10.9% | +0.8% | +17.9% | -24.0% | -94.0% | +1,199.3% | +28.6% | -48.8% | +4.8% | +86.4% | +134.9% | -69.1% | -21.1% | -67.0% | -97.7% | +12,216.1% | -94.8% | +2,055.6% | +123.3% | +69.5% | -86.9% | +673.5% | +272.1% | -91.2% | +466.1% | -41.2% | +200.0% | -97.1% | +1,647.3% | +55.2% | +3.7% | -83.5% | +0.8% | +11.6% | +20.4% | +23.9% | -28.8% | – | |
| – | +25.2% | -19.0% | +62.4% | -20.7% | +33.7% | -27.5% | +5.1% | +43.0% | -1.8% | +5.5% | +10.5% | -18.2% | +0.2% | +7.3% | -15.9% | -7.7% | +32.4% | -26.2% | +5.8% | -5.7% | +8.5% | +7.3% | -14.5% | +0.4% | -14.8% | +2.8% | -5.1% | -13.7% | -1.3% | -17.2% | +7.4% | -13.2% | +27.4% | -14.7% | +41.8% | -14.2% | +23.9% | -7.5% | -12.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +113.3% | -147.7% | – | – | -230.5% | – | – | – | – | – | – | – | – | – | -109.2% | – | – | – | – | +80.6% | -157.5% | – | +81.8% | -318.6% | – | -77.9% | – | |
| – | +773.6% | -73.7% | +45.9% | +20.9% | +7.6% | -44.0% | -19.2% | +1.0% | +2.8% | +3.2% | -0.7% | +7.5% | +1.9% | +54.6% | -39.7% | +1.3% | +27.8% | -14.5% | +2.2% | +9.4% | -62.3% | -31.9% | +0.8% | +2.6% | +1.7% | -0.2% | +101.1% | -64.8% | +68.3% | -49.6% | -5.9% | -18.5% | -98.0% | +0.0% | +12,950.0% | -77.0% | +112.8% | -49.6% | +156.0% | – | |
| – | – | – | – | -2,641.6% | – | – | – | – | – | – | – | – | – | +472.9% | -349.0% | – | – | -1,479.1% | – | – | – | – | – | – | – | – | – | -108.7% | – | – | – | – | +90.4% | -151.0% | – | +238.7% | -313.3% | – | -77.0% | – | |
| – | -170.5% | – | +45.9% | -99.7% | +11,350.0% | -85.6% | -43.2% | +206.7% | -57.0% | +91.9% | -98.4% | +1,033.3% | +429.4% | +12.8% | -81.3% | +210.5% | -279.7% | – | -94.2% | -25.0% | +845.8% | -54.2% | -145.7% | – | +19.9% | -63.2% | +57.9% | -56.8% | -387.2% | – | – | – | +35.4% | -113.7% | – | -123.3% | – | +287.9% | -61.7% | – | |
| – | – | – | – | -2,641.6% | – | – | – | – | – | -174.3% | – | – | – | +472.9% | -349.0% | – | – | -1,479.1% | – | – | – | – | – | – | – | – | – | -109.6% | – | – | – | – | +100.7% | -155.7% | – | +1,336.0% | -333.7% | – | -79.4% | – | |
| – | – | – | – | -282.6% | – | – | – | – | – | -141.0% | – | – | – | +88.8% | -135.4% | – | – | -194.5% | – | – | – | – | – | – | – | – | – | -104.5% | – | – | – | – | +71.2% | -144.1% | – | +54.7% | -243.5% | – | -73.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.